Coq6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
COQ6 Gene (Coenzyme Q Biosynthesis Factor 6) provides instructions for making the COQ6 protein, a mitochondrial flavin-dependent monooxygenase that catalyzes hydroxylation reactions in coenzyme Q (CoQ10) biosynthesis. The COQ6 protein is essential for converting demethoxy-ubiquinone (DMQ) to ubiquinone (CoQ10), a critical component of the mitochondrial electron transport chain.
| Gene Symbol | COQ6 |
|---|
| Full Name | Coenzyme Q Biosynthesis Factor 6 |
|---|
| Chromosomal Location | 14q11.2 |
|---|
| NCBI Gene ID | 51002 |
|---|
| OMIM | 614647 |
|---|
| Ensembl ID | ENSG00000137831 |
|---|
| UniProt ID | Q9Y2Z4 |
|---|
The COQ6 gene contains:
- Exons: 7 coding exons
- Transcript length: ~1.5 kb coding sequence
- Protein length: 455 amino acids
- Molecular weight: ~51 kDa
COQ6 encodes a FAD-dependent monooxygenase that catalyzes:
- C5-hydroxylation of demethoxy-ubiquinone (DMQ)
- Essential ring modification in CoQ10 synthesis
- Requires FAD and NADPH as cofactors
The COQ6 protein supports mitochondrial function:
- Electron Transport Chain - Enables proper Complex I and II function
- Oxidative Phosphorylation - Supports ATP production
- Membrane Potential - Maintains mitochondrial membrane potential
- ROS Regulation - Reduces electron leak and superoxide production
COQ6 is expressed in multiple tissues:
- Brain - Throughout the CNS, high in metabolically active neurons
- Heart - Cardiac muscle with high energy demands
- Liver - Metabolic hub
- Kidney - Renal cortex
- Muscle - Skeletal muscle fibers
- Cerebral Cortex - Layer 5 pyramidal neurons
- Hippocampus - CA1-CA3 pyramidal neurons
- Cerebellum - Purkinje cells
- Substantia Nigra - Dopaminergic neurons
- Brainstem - Various nuclei
COQ6 mutations cause primary CoQ10 deficiency with:
- Steroid-resistant nephrotic syndrome - Kidney disease with proteinuria
- Sensorineural hearing loss - Progressive deafness
- Ataxia - Cerebellar ataxia
- Encephalomyopathy - Neurological and muscular impairment
- Developmental delay - Neurodevelopmental abnormalities
- Mitochondrial Complex I deficiency in PD substantia nigra
- CoQ10 levels reduced in PD patient brains
- COQ6 variants may modify PD risk
- CoQ10 supplementation trials
- Mitochondrial dysfunction in AD
- CoQ10 levels decline with age
- Oxidative stress in AD brain
- CoQ10 therapeutic potential
- Energy metabolism deficits
- Mitochondrial dysfunction
- CoQ10 tested in ALS trials
- CoQ10 deficiency reported
- Mitochondrial defects
- Candidate for therapy
| Treatment |
Mechanism |
Status |
| Ubiquinol (CoQ10) |
Electron carrier, antioxidant |
Supplements |
| Idebenone |
Synthetic analog |
Approved |
| MitoQ |
Mitochondria-targeted |
Research |
| CoQ10 + vitamin E |
Combined antioxidant |
Studies |
- Gene therapy approaches
- Mitochondria-targeted antioxidants
- CoQ pathway activators
- Combination mitochondrial therapies
- Coq6 knockout mice - Embryonic lethal
- Zebrafish coq6 - Renal and neurological phenotypes
- Drosophila models - Useful for screening
The study of Coq6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Heeringa SF, et al. (2011). COQ6 mutations cause steroid-resistant nephrotic syndrome. Nat Genet 43(5):442-5. PMID:21727188
- Gianazza E, et al. (2016). Mitochondrial coenzyme Q6. J Nephrol 29(3):305-12. PMID:26663225
- Desbats MA, et al. (2015). Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta 1857(8):1079-85. PMID:25999232
- Stefely JA, et al. (2016). Mitochondrial protein enrichment. Mol Cell Proteomics 15(10):3284-3295. PMID:27466201